Key result
MI with non-obstructive coronary artery (MINOCA) presenting with STEMI is a heterogeneous condition with comparable mortality to conventional ACS, requiring targeted investigations to determine the underlying aetiology.
Why the study?
MINOCA has comparable mortality to ACS with obstructive disease, but its heterogeneous aetiology makes assessment and treatment challenging, especially when presenting with STEMI.
MINOCA presenting as STEMI is a non-benign condition that requires a meticulous diagnostic approach, including intracoronary imaging and cardiac MRI, to identify the specific etiology and tailor management.
MINOCA-STEMI warrants etiological workup given comparable mortality; leaves open standardized protocols pending prospective data.
MI with non-obstructive coronary artery (MINOCA) is a condition previously thought to be benign that has recently been shown to have comparable mortality to that of acute coronary syndrome with obstructive coronary disease. The heterogeneity of the underlying aetiology makes the assessment, investigation and treatment of patients with MINOCA challenging. The majority of patients with MINOCA presenting with ST-segment elevation MI generally have an underlying coronary or myocardial cause, predominantly plaque disruption or myocarditis. In order to make the correct diagnosis, in addition to the cause of the presentation, a meticulous and methodical approach is required, with targeted investigations. Stratification of patients to guide investigations that are more likely to provide the diagnosis will allow the correct treatment to be initiated promptly. In this article, the authors review the contemporary incidence, aetiology, recommended assessment and treatment of patients with MINOCA presenting with ST-segment elevation MI.
No takes yet. Share an insight, caveat, or question.
Gue et al. (2020) conducted a review in MI with non-obstructive coronary artery (MINOCA) presenting with STEMI. MI with non-obstructive coronary artery (MINOCA) presenting with STEMI is a heterogeneous condition with comparable mortality to conventional ACS, requiring targeted investigations to determine the underlying aetiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: